ProAssurance Co. (NYSE:PRA) Shares Bought by AQR Capital Management LLC

AQR Capital Management LLC raised its holdings in ProAssurance Co. (NYSE:PRA - Free Report) by 25.7% in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 243,834 shares of the insurance provider's stock after buying an additional 49,851 shares during the quarter. AQR Capital Management LLC owned approximately 0.48% of ProAssurance worth $2,980,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in the business. Bank of New York Mellon Corp grew its holdings in shares of ProAssurance by 2.1% during the 2nd quarter. Bank of New York Mellon Corp now owns 417,150 shares of the insurance provider's stock worth $5,098,000 after purchasing an additional 8,549 shares during the period. American Century Companies Inc. grew its holdings in shares of ProAssurance by 4.7% during the 2nd quarter. American Century Companies Inc. now owns 305,698 shares of the insurance provider's stock worth $3,736,000 after purchasing an additional 13,650 shares during the period. Assenagon Asset Management S.A. grew its holdings in shares of ProAssurance by 2.4% during the 2nd quarter. Assenagon Asset Management S.A. now owns 253,649 shares of the insurance provider's stock worth $3,100,000 after purchasing an additional 6,062 shares during the period. Cubist Systematic Strategies LLC grew its holdings in shares of ProAssurance by 567.5% during the 2nd quarter. Cubist Systematic Strategies LLC now owns 151,434 shares of the insurance provider's stock worth $1,851,000 after purchasing an additional 128,747 shares during the period. Finally, Public Sector Pension Investment Board grew its holdings in shares of ProAssurance by 6.1% during the 2nd quarter. Public Sector Pension Investment Board now owns 112,203 shares of the insurance provider's stock worth $1,371,000 after purchasing an additional 6,437 shares during the period. Hedge funds and other institutional investors own 85.58% of the company's stock.

Analyst Upgrades and Downgrades

A number of analysts have recently issued reports on PRA shares. Truist Financial decreased their target price on ProAssurance from $16.00 to $14.00 and set a "hold" rating for the company in a report on Monday, August 12th. JMP Securities decreased their target price on ProAssurance from $22.00 to $20.00 and set a "market outperform" rating for the company in a report on Wednesday, July 17th.

ProAssurance Stock Down 0.2 %

ProAssurance stock traded down $0.03 during midday trading on Tuesday, hitting $14.37. 219,560 shares of the company were exchanged, compared to its average volume of 289,140. The company's fifty day moving average price is $13.48 and its 200-day moving average price is $13.21. The company has a market cap of $733.04 million, a PE ratio of -26.61 and a beta of 0.24. The company has a debt-to-equity ratio of 0.38, a current ratio of 0.26 and a quick ratio of 0.26. ProAssurance Co. has a fifty-two week low of $10.76 and a fifty-two week high of $18.98.

ProAssurance (NYSE:PRA - Get Free Report) last released its quarterly earnings results on Thursday, August 8th. The insurance provider reported $0.23 EPS for the quarter, topping the consensus estimate of $0.08 by $0.15. The firm had revenue of $290.30 million for the quarter, compared to analyst estimates of $235.61 million. ProAssurance had a positive return on equity of 0.86% and a negative net margin of 2.00%. ProAssurance's revenue for the quarter was down .5% on a year-over-year basis. During the same period in the previous year, the company posted $0.16 EPS. On average, research analysts predict that ProAssurance Co. will post 0.58 EPS for the current fiscal year.

ProAssurance Profile

ProAssurance Corporation, through its subsidiaries, provides property and casualty insurance, and reinsurance products in the United States. The company operates through Specialty Property and Casualty, Workers' Compensation Insurance, and Segregated Portfolio Cell Reinsurance segments. It offers professional liability insurance to healthcare providers and institutions, and attorneys and their firms; medical technology liability insurance to medical technology and life sciences companies; and custom alternative risk solutions, including assumed reinsurance, loss portfolio transfers, and captive cell programs for healthcare professional liability insureds.